| scholarly article | Q13442814 |
| P2093 | author name string | Richard A Lange | |
| L David Hillis | |||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | heart disease | Q190805 |
| coronary artery disease | Q844935 | ||
| P304 | page(s) | 277-80 | |
| P577 | publication date | 2004-01-15 | |
| P1433 | published in | The New England Journal of Medicine | Q582728 |
| P1476 | title | Antiplatelet therapy for ischemic heart disease | |
| P478 | volume | 350 |
| Q28181298 | Advances in adjunctive pharmacological therapy for percutaneous coronary interventions |
| Q34775088 | Antithrombotic and antiplatelet activities of Soshiho-tang extract |
| Q42872249 | Aortic dissection presenting as acute myocardial infarction: potential harm of antithrombin and antiplatelet therapy |
| Q37730309 | Aspirin dosing for the prevention and treatment of ischemic stroke: an indication-specific review of the literature |
| Q42025106 | Biological effects of fucoidan isolated from Fucus vesiculosus on thrombosis and vascular cells |
| Q87049826 | Changes in drug prescribing to Italian community-dwelling elderly people: the EPIFARM-Elderly Project 2000-2010 |
| Q36800844 | Clinical characteristics associated with high on-treatment platelet reactivity of patients undergoing PCI after a 300 mg loading dose of clopidogrel, measured by thrombelastography |
| Q49980042 | Design and Rationale for comParison Between ticagreLor and clopidogrEl on mIcrocirculation in Patients with Acute cOronary Syndrome Undergoing Percutaneous Coronary Intervention (PLEIO) Trial |
| Q64118507 | Determinants of high platelet reactivity in patients with acute coronary syndromes treated with ticagrelor |
| Q40240752 | Does organisational culture influence prescribing in care homes for older people? A new direction for research |
| Q50513986 | Effect of Aspirin and ibuprofen either alone or in combination on gastric mucosa and bleeding time and on serum prostaglandin E2 and thromboxane A2 levels in the anaesthetized rats in vivo. |
| Q41049503 | Effect of palm-based tocotrienols and tocopherol mixture supplementation on platelet aggregation in subjects with metabolic syndrome: a randomised controlled trial |
| Q38131848 | Genetics of platelet inhibitor treatment |
| Q37907918 | Genotypic and phenotypic assessment of platelet function and response to P2Y12 antagonists |
| Q28239975 | Guidelines for percutaneous coronary interventions. The Task Force for Percutaneous Coronary Interventions of the European Society of Cardiology |
| Q30450312 | High platelet reactivity on clopidogrel therapy correlates with increased coronary atherosclerosis and calcification: a volumetric intravascular ultrasound study |
| Q34440046 | Immunotargeting of collagenase on thrombus |
| Q58799733 | Metabolism of ticagrelor in patients with acute coronary syndromes |
| Q35808308 | Myocardial infarction centres: the way forward |
| Q28221328 | Optimal management of platelet function after coronary stenting |
| Q44550571 | Public response to chest pain in Jordan |
| Q38048837 | Role of genotype-based personalized antiplatelet therapy in the era of potent P2Y₁₂ receptor inhibitors |
| Q28186141 | Study for determination of the optimal cessation period of therapy with anti-platelet agents prior to invasive endoscopic procedures |
| Q28085710 | The exposome concept in a human nutrigenomics study: evaluating the impact of exposure to a complex mixture of phytochemicals using transcriptomics signatures |
| Q21296645 | Thrombopoietin as biomarker and mediator of cardiovascular damage in critical diseases |
Search more.